AC Immune SA Beta
Что обозначает Beta в AC Immune SA?
Beta AC Immune SA является 0.82
Какое определение для Beta?
БЕТА показывает, если акция является более или менее волатильной, чем рынок в целом. Бета меньше 1 указывает на то, что акции менее волатильные, чем рынок, а бета больше 1 указывает на то, что акции более волатильные. Волатильность измеряется как колебание цены вокруг среднего значения.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta компаний в Health Care сектор на NASDAQ по сравнению с AC Immune SA
Что делает AC Immune SA?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Компании с beta похож на AC Immune SA
- Punjab National Bank имеет Beta из 0.82
- ALSO AG имеет Beta из 0.82
- Pantronics имеет Beta из 0.82
- RIWI имеет Beta из 0.82
- SFL Ltd имеет Beta из 0.82
- Tantech Ltd имеет Beta из 0.82
- AC Immune SA имеет Beta из 0.82
- Greenlam Industries имеет Beta из 0.82
- POCL Enterprises имеет Beta из 0.82
- Tech Mahindra имеет Beta из 0.82
- Southern Arc Minerals имеет Beta из 0.82
- TSS имеет Beta из 0.82
- LifeTech Scientific имеет Beta из 0.82